Latest Stock Market News

The Nifty Pharma index closed 0.96 per cent down at 17154.0.

Nifty on Wednesday ended 460 points lower to form a red candle on the daily charts with a decisive break below the 20-day moving average of 21,629. Both price and momentum indicators are pointing toward weakness.

​Capital markets regulator Sebi has renewed its recognition to AMC Repo Clearing Ltd as a clearing corporation for one year for clearing and settling transactions in repo and reverse repo in debt securities.

Aditya Agarwala believes that the markets are still making higher highs and higher lows, indicating that the trend has not reversed yet. However, the Nifty is facing resistance at the 21,800 level, and if the support levels of 21,600 and 21,500 are broken, there could be a longer correction. Aditya Agarwala suggests that if the Nifty slips below 21,500, it could potentially reach levels of 20,800 or even 20,500. In terms of trading ideas, Aditya recommends buying Infosys and MFSL.

Sensex records worst daily performance in 16 months due to the decline in HDFC Bank shares. The HDFC Bank report card had a spillover effect on other banking stocks, with Nifty Bank crashing along with mid and smallcap indices. Rising bond yields in the US contribute to the negative sentiment in the global market.

A total of 5,245 shares changed hands on the counter till 02:14PM (IST)

Maxposure IPO is completely a fresh equity issue of 61.4 lakh shares and through the issue, the company plans to raise Rs 20.26 crore. The net proceeds will be used for funding expenses incurred towards various certifications from various regulators, working capital requirements, repayment of debt, and general corporate purposes.

Gopal Balachandran says, “In retail health, we grew in excess of 19% on a nine-month basis; the industry numbers were slightly lower than 19%. So, in that sense, we are actually trying to grow faster than the market. We are continuing to make investments in expanding distribution, equally significantly kind of excelling service capability and creating the right product portfolio.